Literature DB >> 28494340

Simple and rapid quantification of vancomycin in serum, urine and peritoneal/pleural effusion via UHPLC-MS/MS applicable to personalized antibiotic dosing research.

Lenka Javorska1, Lenka Kujovska Krcmova2, Petr Solich3, Milan Kaska4.   

Abstract

Management of the therapy of life-threatening bacterial infection is extremely based on an optimal antibiotic treatment. Achieving the correct vancomycin dosage in blood and target tissues can be complicated in special situations, e.g., where large fluid sequestration and/or acute renal failure occur. A UHPLC-MS/MS method operating in electrospray (ESI) positive ion mode was applied for the determination of vancomycin in serum, urine and peritoneal/pleural effusion. Sample pretreatment was composed of dilution and simple protein precipitation where only a small volume (50μL) of serum, urine or peritoneal/pleural effusion was required. The separation of vancomycin was performed on a Meteoric Core C18 BIO column (100×4.6mm, 2.7μm) by gradient elution with 0.1% formic acid in water and acetonitrile. The total time of analysis was 4.5min. The method was found to be linear in the range of 2-60μM (or 0.5-10μM) for serum, 0.27-10μM (or 2-60μM) for peritoneal/pleural effusion and 25-300μM for urine, which was adequate for the determination of vancomycin in patient samples. The intra- and inter-day precision was below 8% RSD, and accuracy was from 89 to 104%. The UHPLC/MS-MS method offers a fast and reliable approach to determine vancomycin concentrations in three different human body fluid samples (serum, urine and peritoneal/pleural effusion) with a simple sample pretreatment that was the same for all selected specimens. This method should be applicable to large sample series in clinical (pharmacokinetic/pharmacodynamic) studies.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Peritoneal/pleural effusion; Serum; UHPLC–MS/MS; Urine; Vancomycin

Mesh:

Substances:

Year:  2017        PMID: 28494340     DOI: 10.1016/j.jpba.2017.04.029

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  A whole blood microsampling assay for vancomycin: development, validation and application for pediatric clinical study.

Authors:  Ganesh S Moorthy; Kevin J Downes; Christina Vedar; Athena F Zuppa
Journal:  Bioanalysis       Date:  2020-09-18       Impact factor: 2.681

2.  Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement.

Authors:  Bita Shahrami; Farhad Najmeddin; Saeideh Ghaffari; Atabak Najafi; Mohammad Reza Rouini; Mojtaba Mojtahedzadeh
Journal:  Crit Care Res Pract       Date:  2020-12-24

3.  Utility of Silver-nanoparticles for Nano-fluorimetric Determination of Vancomycin Hydrochloride in Pharmaceutical Formulation and Biological Fluids: Greenness Assessment.

Authors:  Ahmed R Mohamed
Journal:  J Fluoresc       Date:  2022-06-25       Impact factor: 2.525

4.  A novel sensitive analytical method for the simultaneous analysis of vancomycin and teicoplanin in human urine via single high-performance liquid chromatography coupled with photodiode array and mass spectrometry in series.

Authors:  Maria Giakoumaki; Yiannis Sarigiannis; Evroula Hapeshi
Journal:  J Sep Sci       Date:  2022-05-20       Impact factor: 3.614

5.  Studies on the metabolism and degradation of vancomycin in simulated in vitro and aquatic environment by UHPLC-Triple-TOF-MS/MS.

Authors:  Mengsi Cao; Yanru Feng; Yan Zhang; Weijun Kang; Kaoqi Lian; Lianfeng Ai
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

6.  A Comparative Study of Liquid-Based Cytology and DNA Image Cytometry in the Diagnosis of Serous Effusion.

Authors:  Shaohua Wang; Dan Li; Jieqiong Wang; Yu Wan; Conggai Huang; Bo Yang; Xiaoqin Tang; Gang Tian; Zhihui Yang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.